Declaration

May 06, 2020   |   Firm News

Declaration Partners anchor investor David Rubenstein interviews global leaders on COVID-19

https://declarationpartners.com/wp-content/uploads/2022/02/Screenshot-2022-02-16-at-19.39.36.png

Declaration is proud to support Synthego Corporation advance its cutting-edge genome engineering platform, which accelerates the field of CRISPR-based innovation from early-phase research through the clinic.

 

https://www.prnewswire.com/news-releases/synthego-raises-200-million-to-accelerate-the-field-of-crispr-based-medicines-from-early-phase-research-to-the-clinic-301484417.html